ClinicalTrials.gov
ClinicalTrials.gov Menu

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00575055
Recruitment Status : Completed
First Posted : December 17, 2007
Last Update Posted : November 25, 2013
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2012
  Actual Study Completion Date : April 2012
  Certification/Extension First Submitted : September 27, 2013
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):